Tyers Asset Management’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$463K Hold
7,712
0.02% 499
2019
Q2
$431K Sell
7,712
-240
-3% -$12.4K 0.01% 519
2019
Q1
$443K Buy
7,952
+1,024
+15% +$52.2K 0.02% 503
2018
Q4
$312K Buy
6,928
+368
+6% +$20.2K 0.01% 541
2018
Q3
$432K Buy
6,560
+1,664
+34% +$103K 0.01% 536
2018
Q2
$315K Hold
4,896
0.01% 551
2018
Q1
$271K Hold
4,896
0.01% 593
2017
Q4
$234K Buy
4,896
+944
+24% +$46.2K 0.01% 644
2017
Q3
$200K Buy
3,952
+592
+18% +$30.4K 0.01% 641
2017
Q2
$183K Buy
3,360
+1,024
+44% +$48.9K 0.01% 623
2017
Q1
$98K Buy
2,336
+224
+11% +$9.57K ﹤0.01% 674
2016
Q4
$91K Buy
+2,112
New +$85.8K ﹤0.01% 669

Other funds holding IART

Tyers Asset Management's IART Position: Q3 2019 in Review

Tyers Asset Management held its Integra LifeSciences (IART) position steady in Q3 2019 at 7,712 shares worth $463K. The position accounts for 0.02% of the portfolio, ranked #499.

Tyers Asset Management first reported a position in IART in Q4 2016 and has held it in 12 quarters since. 280 funds tracked by Wall St. Rank hold IART as of Q3 2019.

  • Tyers Asset Management held 7,712 shares of Integra LifeSciences worth $463K as of Q3 2019.
  • Tyers Asset Management left its Integra LifeSciences share count unchanged in Q3 2019.
  • Integra LifeSciences made up 0.02% of Tyers Asset Management's portfolio in Q3 2019, its #499 holding.
  • Tyers Asset Management first reported a position in Integra LifeSciences in Q4 2016 and has held it in 12 quarters since.
  • 280 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.